OOIR: Observatory of International Research

Papers

(The TQCC of Hematology-Oncology Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver	148
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	76
Autoimmune Hemolytic Anemia: An Old Disease with New Twists	43
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	39
Conflict and Access to Health Care	39
Copyright	38
Managing First-Line Metastatic Renal Cell Carcinoma	38
Forthcoming Issues	36
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis	35
Treatment of High-Risk Gestational Trophoblastic Neoplasia	31
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	31
Advances in Gastric Cancer Surgical Management	27
Updates in the Management of Warm Autoimmune Hemolytic Anemia	27
Benefits and Harms of Interception and Early Detection of Cancer	27
Future Directions for Gestational Trophoblastic Disease	26
Hematology/Oncology Clinics of North America	25
Contributors	24
Contributors	22
Contents	22
Copyright	20
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	17
Disparities in Breast Cancer Outcomes and How to Resolve Them	17
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	17
The Landscape of Personalized Medicine in Gynecologic Cancer	17
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	16

Liposarcoma	15
Contents	15
Advances in Immunotherapy in Esophagogastric Cancer	15
Histiocytic Disorders in Pediatric and Adult Patients	14
Advances in Systemic Therapy in Pancreatic Cancer	14
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma	14
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas	13
Emerging Therapies in β-Thalassemia	13
Advances in Surgical Techniques for Lung Cancer	13
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	13
Foreword	13
Clinical Characteristics and Treatment of Histiocytic Disorders in Children	13
Forthcoming Issues	12
Adult Evans' Syndrome	12
Red Cell Antigens and Antibodies	12
Genomic Alterations in Langerhans Cell Histiocytosis	12
Copyright	12
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors	12
Evaluation and Management of Bing–Neel Syndrome	11
Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer	11
Clinical Vignettes Part I	11
Skin Cancer Precursors	11
Forthcoming Issues	10
Hereditary Renal Cell Carcinoma Syndromes	10
Copyright	10
Genes as Medicine	10
Gestational Trophoblastic Neoplasia	10
Malignancies of the Upper Gastrointestinal Tract	10
High-Risk Non-Melanoma Skin Cancers	10
New Developments in Myeloma	9
Contents	9
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities	9
Patient-Reported Outcomes in Radiation Oncology	9
Local Control in Soft Tissue Sarcomas	9
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	9
Advances in the Surgical Management of Esophageal Cancer	9
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma	8
Bispecific Antibodies in the Treatment of Multiple Myeloma	8
Forthcoming Issues	8
Heavy Ion Particle Therapy in Modern Day Radiation Oncology	8
Melanoma Brain Metastasis	8
Evolution of Gene Therapy, Historical Perspective	8
Copyright	7
Contents	7
Copyright	7
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers	7
Breast Cancer in India	7
Contents	7
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer	7
Breast Cancer and Lifestyle Factors	7

Hemophilia A/B	7
Radiation-Induced Tissue Regeneration	7
Disparities and Inequities Among Patients with Central Nervous System Tumor	7
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms	7
Education and Training Models for Remote Learning	7
Clinical Complications and Their Management	6
Ductal Carcinoma In Situ	6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies	6
Copyright	6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma	6
FLASH Radiotherapy	6
Early Detection of Precursor Diseases of Multiple Myeloma	6
Targeted Therapy Innovations for Melanoma	6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?	6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors	6
Impact of Clonal Heterogeneity in Multiple Myeloma	6
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases	6
Contributors	5
Merkel Cell Carcinoma	5
Pathogenic Mechanisms in Thalassemia II	5
Forthcoming Issues	5
Approach to High-Risk Multiple Myeloma	5
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing	5
Copyright	5
Immunotherapy-associated Autoimmune Hemolytic Anemia	5
Advances in Cervical Cancer	5
Pathogenic Mechanisms in Thalassemia I	5
Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia	5
Contents	5
Immune-Pathogenesis of Myeloma	5
Genetics and Genomics of Gestational Trophoblastic Disease	5
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	5
Surgery for Recurrent Ovarian Cancer	5
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	5
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors	5
Complications of Autoimmune Hemolytic Anemia	5
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia	5
Sarcomas	5
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy	5
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)	4
Renal Cell Cancer	4
Debate	4
Functional Radiosurgery in the Management of Cancer Pain	4
Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma	4
Contents	4
Gastrointestinal Cancer Precursor Conditions and Their Detection	4
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia	4
Innovation and Emerging Technologies in Radiation Oncology	4
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity	4
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia	4
Role of Radiation in Treatment of Renal Cell Carcinoma	4
Management of Waldenström Macroglobulinemia in Limited-Resource Settings	4
Contributors	4
Escalation, De-escalation, Adaptation, Speciation, Customization: The New Approaches to Breast Cancer	4
Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH)	4
Role of Ovarian Suppression in Early Premenopausal Breast Cancer	4
Chronic Lymphocytic Leukemia	4
Preface	4
Contents	4
Cutaneous T-cell Lymphoma	4
Contents	4
Local Therapies in Advanced Colorectal Cancer	4
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	4
Contents	4
Remembering the Contributions of Professor David J. Weatherall	4
Hereditary Colorectal Cancer	4
Biology and Treatment of Meningiomas	4
Breast Cancer Pathology in the Era of Genomics	4
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer	4
Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?	4
Waldenström Macroglobulinemia	4
Smoldering Multiple Myeloma	4
Regulatory Aspects of Gene Therapy	4